Study of TAK-733 in Combination With Alisertib in Adult Patients With Advanced Nonhematologic Malignancies
Clinical trial NCT01613261 · WITHDRAWN
Trial details
- NCT number
- NCT01613261
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2015-09-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.